Moderna and the National Institutes of Health (NIH) are in a patent dispute over the company’s messenger RNA (mRNA)-based COVID-19 vaccine developed with the aid of government scientists. Source: Drug…
Inovio has received the FDA go-ahead for a phase 3 trial of INO-4800, a DNA plasmid vaccine against COVID-19. Source: Drug Industry Daily
The biomarker known as circulating tumor DNA (ctDNA) is well-suited to become an early endpoint in oncology, as it has the potential to improve confidence in the efficacy of novel…
AstraZeneca is setting up a new business unit dedicated to overseeing its vaccines and antibody therapies as it looks to rebound from pandemic-era disappointments related to its COVID-19 jab co-developed…
A new national registry, sponsored by the Alzheimer’s Association, will track real-world outcomes data for Alzheimer’s patients receiving FDA-approved treatments for the disease, including the antiamyloid antibody Aduhelm. Source: Drug…
The problems inherent in studying antibiotic-resistant bacteria could be better solved with a widespread automated system that pulls real-world data from electronic health records (EHR). Source: Drug Industry Daily
The main substance in Covis Pharma’s premature birth drug Makena — a synthetic hormone known as 17α-hydroxyprogesterone caproate (17-OHPC) — has been linked with an increased risk of cancer in…
Ten of the nation’s highest-ranked hospitals charge health insurance companies and patients paying out of pocket far more than the amount Medicare pays for several infused drugs, according to a…
Pfizer and BioNTech are seeking an amended Emergency Use Authorization (EUA) from the FDA allowing their COVID-19 vaccine booster for general use in adults over age 18. Source: Drug Industry…
Biogen is investigating the death of a 75-year-old patient from cerebral edema that was possibly related to the antiamyloid antibody Aduhelm. Source: Drug Industry Daily